Zaleplon: a pyrazolopyrimidine sedative-hypnotic agent for the treatment of insomnia
- 1 November 2000
- journal article
- review article
- Published by Elsevier in Clinical Therapeutics
- Vol. 22 (11) , 1254-1267
- https://doi.org/10.1016/s0149-2918(00)83024-6
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- A comparison of the residual effects of zaleplon and zolpidem following administration 5 to 2 h before awakeningBritish Journal of Clinical Pharmacology, 1999
- Zaleplon, A Novel Nonbenzodiazepine Hypnotic, Effectively Treats Insomnia in Elderly Patients Without Causing Rebound EffectsThe Primary Care Companion For CNS Disorders, 1999
- A Comparative Assessment of the Risks and Benefits of ZopicloneDrug Safety, 1999
- Efficacy of L‐846 in patients with insomnia:Evaluation by polysomnographyPsychiatry and Clinical Neurosciences, 1998
- Metabolism of Zaleplon by human hepatic microsomal cytochrome P450 isoformsXenobiotica, 1998
- Anxiolytics’ Effects on the Actual Driving Performance of Patients and Healthy Volunteers in a Standardized TestNeuropsychobiology, 1995
- A Placebo‐Controlled Evaluation of Single, Escalating Doses of CL 284,846, a Non‐Benzodiazepine HypnoticThe Journal of Clinical Pharmacology, 1994
- The benzodiazepine withdrawal symptom questionnaireJournal of Affective Disorders, 1990
- The Diagnosis and Management of InsomniaNew England Journal of Medicine, 1990
- Factor analysis of a sleep evaluation questionnairePsychological Medicine, 1978